Patents by Inventor JEAN-PAUL IYOMBE-ENGEMBE

JEAN-PAUL IYOMBE-ENGEMBE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190248854
    Abstract: Methods for modifying a dystrophin gene are disclosed, for restoring dystrophin expression within a cell having an endogenous frameshift or nonsense mutation within the dystrophin gene. The methods comprise introducing a first cut within an exon en or intron of the dystrophin gene creating a first exon end or intron end, wherein said first cut is located upstream of the endogenous frameshift or nonsense mutation; and introducing a second cut within an exon or intron of the dystrophin gene creating a second exon end or intron end, wherein said second cut is located downstream of the frameshift or nonsense mutation. Upon joining/ligation of said first and second exon ends or intron ends a hybrid exon or intron junction is created and dystrophin expression is restored, as the correct reading frame is restored. Reagents and uses of the method are also disclosed, for example to treat a subject suffering from muscular dystrophy.
    Type: Application
    Filed: September 21, 2017
    Publication date: August 15, 2019
    Inventors: JACQUES P. TREMBLAY, JEAN-PAUL IYOMBE-ENGEMBE, PIERRE CHAPDELAINE, DANIEL AGUDELO, BENJAMIN DUCHÊNE
  • Publication number: 20180265859
    Abstract: Methods of modifying a dystrophin gene are disclosed, for restoring dystrophin expression within a cell having an endogenous frameshift mutation within the dystrophin gene. The methods comprising introducing a first cut within an exon of the dystrophin gene creating a first exon end, wherein said first cut is located upstream of the endogenous frameshift mutation; and introducing a second cut within an exon of the dystrophin gene creating a second exon end, wherein said second cut is located downstream of the frameshift mutation. Upon joining/ligation of said first and second exon ends dystrophin expression is restored, as the correct reading frame is restored. Reagents and uses of the method are also disclosed, for example to treat a subject suffering from muscular dystrophy.
    Type: Application
    Filed: September 23, 2016
    Publication date: September 20, 2018
    Inventors: JACQUES P. TREMBLAY, JEAN-PAUL IYOMBE-ENGEMBE, PIERRE CHAPDELAINE